As TNBC showed more progressively malignant manifestation with worse clinical outcomes and is the most insensitive subtype of breast cancer to drug treatment, we next explored the correlation of VDAC1 expression with the prognosis of TNBC. This evidence concerns the gene VDAC1 and breast cancer.